(Q36632222)

15 August 2017

1 reference

title

Pharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome (English)

1 reference

15 August 2017

0 references

0 references

pacemaker implantation

1 reference

3

Andrzej Kutarski

1 reference

15 August 2017

Piotr Rucinski

1

1 reference

15 August 2017

Andrzej Rubaj

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Expert Opinion on Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

16

1 reference

15 August 2017

page(s)

2203-2213

1 reference

The syndrome of alternating bradycardia and tachycardia

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Trends in pacemaker mode prescription 1984-1994: a single centre study of 3710 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

DDD pacing: an effective treatment modality for recurrent atrial arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Drug induced bradycardia: to pace or not to pace?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Effect of amiodarone dose on the risk of permanent pacemaker insertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Optimal cardiac pacing in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Relief of drug refractory angina by biventricular pacing in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy--observations on cardiac memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

The natural history of sick sinus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Acute effects of a class IA antiarrhythmic drug on the ventricular evoked response amplitude in patients with cardiac pacemakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Intravenous theophylline--an alternative to temporary pacing in the management of bradycardia secondary to AV nodal block

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

New devices and hybrid therapies and new devices for treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Hybrid therapy of atrial fibrillation: algorithms and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Prevention of atrial arrhythmias during DDD pacing by atrial overdrive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Intra- and interatrial conduction delay: implications for cardiac pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Dual-site atrial pacing for atrial fibrillation in patients without bradycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Pacing for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Incidence of atrial tachyarrhythmias in pacemaker patients: results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated patients (BEATS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Optimized standby rate reduces the ventricular rate variability in pacemaker patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

Fish intake and risk of incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.16.2203

10.1517/14656566.7.16.2203

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference